Health Bulletin 04/ April/ 2024

Here are the top health news for the day:

NTA reopens NEET 2024 registration window
Through a public notice, the National Testing Agency (NTA) has announced the reopening of the registration window for the National Eligibility-cum-Entrance Test for (Undergraduate) courses- NEET UG 2024.
As per the notice, the NTA, “received various representations from stakeholders with a request to re-open the registration window of NEET (UG)- 2024”.
For more information, click on the link below:

Hepatitis viruses kill 3,500 people a day: WHO

According to the World Health Organization (WHO) 2024 Global Hepatitis Report, the number of lives lost due to viral hepatitis is increasing. The disease is the second leading infectious cause of death globally — with 1.3 million deaths per year, the same as tuberculosis, a top infectious killer.

The report, released at the World Hepatitis Summit, highlights that despite better tools for diagnosis and treatment, and decreasing product prices, testing and treatment coverage rates have stalled. But, reaching the WHO elimination goal by 2030 should still be achievable, if swift actions are taken now.

Kerala PG medico suicide case: HC grants interim relief to accused doctor

Granting interim relief to the doctor accused of abetting his former fiance’s suicide, the Kerala High Court has allowed him to rejoin his post-graduate studies.

This order was passed by a single-judge bench consisting of Justice Ziyad Rahman AA after considering the ‘irreversible damage’ caused by preventing the accused doctor from attending classes, Live Law has reported.

For more information, click on the link below:

Kerala PG Medico Suicide Case: HC Grants Interim Relief To Accused Doctor, Allows To Rejoin MS Orthopaedics Course

H5N1 bird flu vaccine available, no need to panic: Former AIIMS director Dr Randeep Guleria
Recently, H5N1 bird flu has been making headlines due to concerns about its potential to cause a pandemic. This virus, primarily affecting avian species, has sparked global attention amid fears of a potential outbreak that could be significantly more severe than Covid-19. Experts warn that if H5N1 were to mutate into a form capable of human-to-human transmission, it could result in a devastatingly high mortality rate, estimated at 60%.
Addressing these concerns, former AIIMS director Dr. Randeep Guleria has reassured the public that there is no need to panic. He emphasizes that while avian influenza has been present for over two decades, the virus has remained dormant for many years. Additionally, Guleria highlights the existence of a vaccine against H5N1, developed and stockpiled in anticipation of a potential outbreak. Despite the expiration of previous vaccine stockpiles, advancements in technology mean that pharmaceutical companies could swiftly produce new batches if needed. 
Facebook Comments